0.33 (3.45%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Strong
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Website
Satellos Bioscience Inc
Telephone
1.647.660.1780
Address
Suite 2800, 200 Bay Street, Royal Bank Plaza, South Tower, Toronto, ON M5J 2J1
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 6.24 - 18.98
Trade Value (12mth)
US$44,079.00
1 week
-0.5%
1 month
-5.71%
YTD
17.86%
1 year
26.92%
All time high
235.20
EPS 3 yr Growth
-37.50%
EBITDA Margin
0.00%
Operating Cashflow
-$33m
Free Cash Flow Return
-62.20%
ROIC
-65.60%
Interest Coverage
0.00
Quick Ratio
7.80
Shares Outstanding (Fully Diluted)
18m
HALO Sector
Healthcare
Next Company Report Date
26-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
CAD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| CAD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -2.21 | -2.94 | -2.38 | | | | ||
EPS (Fully Diluted) | $ | | | | | -2.21 | -2.94 | -2.38 | | | | ||
Growth | % | | | | | 42.1 | -33.1 | 18.9 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
